| | |
| New research points to turning point in human diet Tuesday, Jun 04, 2013 08:37 PM PDT By Laura Zuckerman (Reuters) - Human ancestors in Africa about 3.4 million years ago expanded their diets beyond the leaves and fruits preferred by most primates and began eating grasses and grass-like plants, setting the stage for expanded habitats, according to new research. The research, by University of Utah geochemist Thure Cerling and an international team of scientists, refutes the previously held belief that those early humans shared the diets of forest-dwelling primates. ... Full Story | Top |
| Komen breast cancer charity cancels walks in seven U.S. cities Tuesday, Jun 04, 2013 07:37 PM PDT | Top |
| Michael Douglas Finds Silver Lining in Cancer Flap Tuesday, Jun 04, 2013 06:12 PM PDT | Top |
| France says tests prove Syria used nerve gas; U.S. sends Patriots to Jordan Tuesday, Jun 04, 2013 04:12 PM PDT | Top |
| Aveo to slash 62 percent jobs; focus on colon, breast cancer drug Tuesday, Jun 04, 2013 03:21 PM PDT (Reuters) - Aveo Pharmaceuticals Inc said it would cut about 62 percent of its workforce, or 140 jobs, to focus on developing its most important drug for colon and breast cancer as it does not expect U.S. regulatory approval for the drug to treat kidney cancer. The company's shares rose 3.2 percent to $2.57 in post-market trading. Aveo also said Chief Operating Officer Elan Ezickson has resigned and would leave at the end of July. His responsibilities will be handled by Chief Commercial Officer Michael Bailey, who is also slated to take up a new role as chief business officer from August. ... Full Story | Top |
| Sebelius says she talked to health firms on Obamacare outreach Tuesday, Jun 04, 2013 02:30 PM PDT | Top |
| KKR, Warburg, Cinven eye bids for clinical trial firm PRA - sources Tuesday, Jun 04, 2013 01:39 PM PDT By Soyoung Kim and Greg Roumeliotis NEW YORK (Reuters) - Private equity firms KKR & Co LP, Warburg Pincus LLC and Cinven Ltd are weighing bids for PRA International, a clinical research group, which is for sale and could fetch as much as $1.3 billion, several people familiar with the matter said. The buyout firms are among the parties preparing to submit second-round bids later in June for Raleigh, North Carolina-based PRA, the sources said this week, asking not to be identified because the auction is not public. ... Full Story | Top |
| Docs have trouble meeting electronic record goals Tuesday, Jun 04, 2013 01:32 PM PDT By Andrew M. Seaman NEW YORK (Reuters Health) - Despite the U.S. government offering hefty financial incentives to doctors for using electronic records to assess the care they provide, a new study says few doctors met the program's criteria last year. Researchers found that only one in 10 doctors with an electronic health records system satisfied the U.S. government's requirements of "meaningful use" by early 2012. ... Full Story | Top |
| Statins linked to muscle pain, sprains Tuesday, Jun 04, 2013 01:28 PM PDT By Genevra Pittman NEW YORK (Reuters Health) - Cholesterol-lowering drugs could be tied to more muscle problems than researchers previously believed, a new study hints. Researchers compared two groups of similar people enrolled in military health insurance and found those taking a statin were about 10 percent more likely to have muscle pain, sprains or strains. Past studies have tied the popular cholesterol drugs to muscle weakness as well as the rare muscle-wasting disease rhabdomyolysis. ... Full Story | Top |
| Accused Colorado gunman James Holmes enters insanity plea Tuesday, Jun 04, 2013 01:02 PM PDT | Top |
| More men treated for low T, some without evidence Tuesday, Jun 04, 2013 11:46 AM PDT By Genevra Pittman NEW YORK (Reuters Health) - The proportion of middle-aged American men being treated for low testosterone more than tripled over the last decade, a new study suggests. Researchers analyzed health insurance claims for more than 10 million men aged 40 and over and found that by 2011, almost 3 percent were taking so-called androgen replacement therapy. But not all of those men had undergone a blood test to see if they really needed the extra testosterone, according to findings published in JAMA Internal Medicine. ... Full Story | Top |
| Group of strong antibiotics linked to kidney injury Tuesday, Jun 04, 2013 11:27 AM PDT By Kathryn Doyle NEW YORK (Reuters Health) - Men taking drugs in the fluoroquinolone family were twice as likely to suffer serious kidney problems as men not taking the powerful antibiotics in a new study. When the participants, aged 40 to 85 years old, also took blood pressure medications known as ACE inhibitors, their kidney risk rose to nearly five times that of similar men not taking fluoroquinolones, which include ciprofloxacin, levofloxacin and moxifloxacin. ... Full Story | Top |
| Bill Gates leads $35 million investment in research network Tuesday, Jun 04, 2013 09:03 AM PDT | Top |
| Vaccine group suspends Sierra Leone support after funds misused Tuesday, Jun 04, 2013 08:09 AM PDT (This is a corrected version of a December 20, 2012 story that was erroneously issued on June 3, 2013 without the correction information appended.) By Simon Akam FREETOWN (Reuters) - A vaccination provider set up with money from the Bill and Melinda Gates Foundation has put on hold some $6 million earmarked for Sierra Leone after an audit showed misuse of previous funds, a document seen by Reuters showed. ... Full Story | Top |
| U.N. rights team believes chemical weapons used in Syria Tuesday, Jun 04, 2013 05:55 AM PDT By Stephanie Nebehay GENEVA (Reuters) - United Nations human rights investigators said on Tuesday they had "reasonable grounds" to believe that limited amounts of chemical weapons had been used in Syria and warned that the shattered country was in "free-fall". In their latest report, they said they had received allegations that Syrian government forces and rebels had used the banned weapons, but most testimony related to their use by state forces. ... Full Story | Top |
|

No comments:
Post a Comment